Evidence map›Paper›PMID 30216993›Full record

ArticleMarine drugs2018

Influence of Modified Fucoidan and Related Sulfated Oligosaccharides on Hematopoiesis in Cyclophosphamide-Induced Mice.

Natalia Yu Anisimova, Nadezhda E Ustyuzhanina, Maria I Bilan, Fedor V Donenko, Natalia A Ushakova, Anatolii I Usov, Mikhail V Kiselevskiy, Nikolay E Nifantiev

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Perspectives for the Use of Fucoidans in Clinical Oncology.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Journal of microbiology and biotechnology · 2020
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Natalia Yu AnisimovaN.N. Blokhin National Medical Research Center of Oncology, Kashirskoe shosse, 24, 115478 Moscow, Russia. n_anisimova@list.ru.ORCID 0000-0002-4370-6578
Nadezhda E UstyuzhaninaN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia. ustnad@gmail.com.
Maria I BilanN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia. bilan@ioc.ac.ru.
Fedor V DonenkoN.N. Blokhin National Medical Research Center of Oncology, Kashirskoe shosse, 24, 115478 Moscow, Russia. donenko.f20010@yandex.ru.
Natalia A UshakovaV.N. Orekhovich Research Institute of Biomedical Chemistry, Pogodinskaya str. 10, 119121 Moscow, Russia. natalia.ushakova@ibmc.msk.ru.
Anatolii I UsovN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia. usov@ioc.ac.ru.
Mikhail V KiselevskiyN.N. Blokhin National Medical Research Center of Oncology, Kashirskoe shosse, 24, 115478 Moscow, Russia. kisele@inbox.ru.
Nikolay E NifantievN.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, 119991 Moscow, Russia. nen@ioc.ac.ru.
N.D. Zelinsky Institute of Organic Chemistry · RUInstitute of Biomedical Chemistry · RUNational Research Nuclear University MEPhI · RURussian Cancer Research Center NN Blokhin · RUYandex (Russia) · RU

Funding

Russian Foundation for Basic Research 17-00-00494, 17-00-00495, 17-00-00496
6 · The paper itself

Abstract

Immunosuppression derived after cytostatics application in cancer chemotherapy is considered as an adverse side effect that leads to deterioration of quality of life and risk of infectious diseases. A linear sulfated (1→3)-α-l-fucan

Indexed as

AnimalsBone MarrowCyclophosphamideDisease Models, AnimalFilgrastimHematologic AgentsHematopoiesisHematopoietic Stem CellsHumansImmunosuppression TherapyMaleMiceMice, Inbred BALB CNeutropeniaNeutrophilsOligosaccharidesCyclophosphamideFilgrastimfucoidanHematologic AgentsOligosaccharidesPolysaccharidesSulfatescyclophosphamidefucoidangranulocyte colony-stimulating factorhematopoiesisimmunosuppressionsynthetic oligosaccharide

Identifiers

PMID30216993
PMCPMC6164909
OpenAlexW2891078429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.